Sodium Chloride Pharmaceutical USP/EP (Pharmacopeial Crystalline NaCl Parenteral Saline Dialysate Tonicity Adjuster) Storage

Sodium Chloride Pharmaceutical USP/EP (Pharmacopeial-Grade Crystalline NaCl for Parenteral + Ophthalmic + Irrigation + Dialysate Manufacturing) Storage — Compendial Sodium Chloride Tank Selection at Large-Volume Parenteral Manufacturing, Hemodialysis-Concentrate, Ophthalmic, and Compounding-Pharmacy Operations

Sodium Chloride Pharmaceutical USP (also called pharmaceutical sodium chloride USP, parenteral-grade NaCl, common salt USP, halite USP; CAS 7647-14-5; molecular formula NaCl; molecular weight 58.44 g/mol) is a white, crystalline, slightly hygroscopic solid produced by mechanical evaporation + recrystallization + purification of brine from solar-salt + rock-salt + vacuum-evaporated salt operations to meet the USP-43-NF-38 Sodium Chloride monograph and Ph. Eur. 11.0 Sodium Chloride monograph. Compendial pharmaceutical sodium chloride specifications: assay 99.0% minimum NaCl on dried basis; identification by sodium ion (flame photometry + sodium-specific tests) + chloride ion (silver chloride precipitation); loss on drying under 0.5% at 105°C for 2 hours; insoluble matter under 0.005% w/w; alkalinity / acidity neutral on litmus / pH 4.5-7.0 in 5% w/v aqueous; bromide under 0.01%; iodide trace negative; nitrite negative; calcium + magnesium combined under 0.005% as Ca; iron under 2 ppm; aluminum under 0.5 ppm (parenteral-grade); arsenic under 1 ppm; barium negative; heavy metals under 5 ppm; phosphate under 0.0025%; sulfate under 0.02%; bacterial endotoxins per USP <85> under 0.5 EU/mg (parenteral-grade); microbial bioburden per USP <61> + <62> (parenteral-grade is typically pyrogen-tested + endotoxin-tested at production and again post-formulation).

Pharmaceutical USP sodium chloride is the iconic + highest-volume pharmaceutical inorganic salt by manufacturing weight; it is the principal active ingredient in 0.9% saline IV crystalloid (the most-administered IV fluid in U.S. + global hospitals; over 250 million liters annually in U.S. alone), 3% hypertonic saline (neurocritical-care + traumatic-brain-injury + hyponatremia treatment), 23.4% hypertonic saline (intracranial-pressure crisis treatment), bacteriostatic saline (preservative-containing 0.9% saline for multi-dose injectable diluent), normal saline ophthalmic irrigation (BSS, balanced salt solution), 0.45% half-strength saline IV crystalloid, ophthalmic hyperosmotic 5% sodium chloride solution + ointment (Muro 128 by Bausch + Lomb), nebulizer + nasal saline irrigation (Ayr Saline Nasal Mist, NeilMed Sinus Rinse, hospital-grade respiratory-therapy saline), dialysis dialysate concentrate (Fresenius + Baxter + DaVita hemodialysis dialysate manufacturing), and many parenteral + ophthalmic + topical formulations as tonicity adjuster + electrolyte. Physical properties: density 2.165 g/cm³ solid; 1.198 g/cm³ saturated brine at 25°C; specific gravity 2.165 solid; viscosity of saturated brine 2.0 cP at 25°C; melting point 801°C; non-flammable + non-combustible at any handling temperature; solubility 360 g/L (35.7 g/100 mL water) at 25°C; saturated brine concentration 26.4% w/w NaCl at 25°C; hygroscopic above 75% RH (deliquescent above 78% RH).

The eight sections below cite USP-NF 43, Ph. Eur. 11.0, JP 18, FDA 21 CFR Parts 210 + 211 + 600-680, USP <85> Bacterial Endotoxins, USP <71> Sterility, USP <788> Particulate Matter, USP <791> pH, USP <1116> Microbial Bioburden, ASME BPE-2022, ICH Q3D + Q3C + Q7, FDA 21 CFR 184.1721 GRAS Sodium Chloride, and operating practice at Cargill (Cargill Salt is a major U.S. pharmaceutical-grade sodium chloride supplier), Morton Salt (now part of Stone Canyon Industries / K+S group), Compass Minerals (formerly North American Salt + International Salt), Akzo Nobel (specialty chemicals), and pharmaceutical manufacturing operations at Baxter International (the dominant U.S. + global IV-saline manufacturer; Mountain Home AR + Marion NC + multiple global sites), Hospira (Pfizer; Rocky Mount NC + multiple sites), B. Braun Medical (Irvine CA + Allentown PA), ICU Medical (Lake Forest IL + multiple sites), Fresenius Kabi (Lake Zurich IL + Wilson NC), Baxter Compounding Services + 503B outsourcing facilities.

1. Material Compatibility Matrix

Pharmaceutical USP sodium chloride is a chemically gentle inorganic salt with no oxidizer character, neutral pH 4.5-7.0 in 5% aqueous, no organic acid character, no halogen-acid reactivity in solid form. Material selection is driven by chloride-induced pitting + crevice corrosion of stainless-steel surfaces at saturated-brine + hot-brine service; HDPE + FRP are inherently chloride-immune. Solid-form crystalline NaCl is non-corrosive in dry handling; aqueous brine + saturated solutions are the corrosion-relevant material-selection driver.

The dominant industrial pattern at pharmaceutical sodium-chloride-using manufacturing depends sharply on the form: (1) Crystalline solid bulk-receipt at the raw-material warehouse via 50-lb bags + 1000-lb supersacks + bulk-pneumatic-truck delivery to silos uses HDPE or carbon-steel + epoxy-coated silos; (2) Saturated brine + concentrated brine bulk-storage uses HDPE or FRP rotomolded tanks rather than 316L due to chloride-pitting corrosion at saturated brine + hot brine + crevice geometries; (3) Dilute saline (under 5% NaCl) parenteral-formulation service uses 316L electropolished sanitary stainless ASME BPE tanks at the formulation kettle level. OneSource Plastics' 5-brand HDPE network is exceptionally well-suited to bulk brine + saturated-brine + dilute-saline storage and ranks above stainless steel at saturated-brine service due to chloride-immune HDPE construction.

2. Real-World Industrial Use Cases

0.9% Saline IV Crystalloid Manufacturing. Pharmaceutical USP sodium chloride is the principal active ingredient in 0.9% saline IV crystalloid (also called normal saline, NS, physiological saline) manufactured at industrial scale for hospital + emergency-department + outpatient infusion-center markets. Baxter International is the dominant U.S. + global manufacturer (Mountain Home AR is the iconic Baxter saline-manufacturing site producing approximately 250 million IV-bags annually); Hospira (Pfizer; Rocky Mount NC + multiple sites), B. Braun Medical (Irvine CA + Allentown PA), ICU Medical (Lake Forest IL + multiple sites), Fresenius Kabi (Lake Zurich IL + Wilson NC) operate at large scale. Annual U.S. saline production exceeds 250 million liters; global production exceeds 1 billion liters. The 2017 + 2018 IV-saline shortages following Hurricane Maria damage to Baxter's Puerto Rico plants underscored the criticality of saline supply-chain redundancy.

Hypertonic Saline Manufacturing. Pharmaceutical USP sodium chloride is the active in 3% hypertonic saline (neurocritical-care + traumatic-brain-injury + hyponatremia treatment), 7.5% hypertonic saline (small-volume resuscitation), and 23.4% hypertonic saline (intracranial-pressure crisis treatment + cerebral-edema management) manufactured at the same large-volume parenteral manufacturers + 503B outsourcing facilities. Hypertonic saline product manufacturing requires especially-pure parenteral-grade NaCl with strict aluminum + endotoxin + heavy-metal limits.

Bacteriostatic Saline + Multi-Dose Diluent. Bacteriostatic saline (0.9% NaCl + 0.9% benzyl alcohol preservative) is manufactured for multi-dose injectable diluent service in oncology + biologic + vaccine reconstitution applications. Manufacturing at Hospira (Pfizer) + Fresenius Kabi + Baxter Compounding.

Ophthalmic Hypertonic Sodium Chloride. USP sodium chloride is the active in 5% sodium chloride ophthalmic hypertonic solution + ointment (Muro 128 by Bausch + Lomb; private-label generic equivalents at Akorn + Sandoz Falcon) for treatment of corneal edema following corneal endothelial dysfunction or post-corneal-transplant + post-cataract-surgery edema management. Ophthalmic-grade USP NaCl requires the strictest aluminum + heavy-metal + endotoxin + microbial-bioburden specifications among pharmaceutical NaCl applications.

Hemodialysis Dialysate Concentrate Manufacturing. Pharmaceutical USP sodium chloride is the principal sodium component in hemodialysis dialysate-concentrate manufacturing for chronic dialysis + acute dialysis + CRRT (continuous renal replacement therapy) clinical service. Concentrate manufacturing at Fresenius Medical Care (Frenova Renal Research; Lewisberry PA + Walnut Creek CA + multiple global sites), Baxter (Renal Therapeutic Services; multiple sites), DaVita Kidney Care (multiple sites). Manufacturing volumes: U.S. dialysate concentrate consumption exceeds 100 million gallons annually serving over 500,000 dialysis patients in U.S. + similar global volumes. Dialysate-grade NaCl requires especially-strict aluminum + bromide + heavy-metal + bacterial-endotoxin limits because dialysate is administered to renal-failure patients with compromised excretion.

Saline Nasal Irrigation + Respiratory Therapy. Pharmaceutical-grade sodium chloride is the active in OTC saline-nasal irrigation + nasal-spray products: NeilMed Sinus Rinse, Arm & Hammer Simply Saline, Ayr Saline Nasal Mist + Gel, Ocean Premium Nasal Spray, hospital + clinic respiratory-therapy 0.9% + 3% saline nebulizer solutions for nebulized-airway-clearance therapy. Manufacturing at Reckitt Benckiser, Bayer Consumer Health, Church & Dwight (Arm & Hammer), private-label manufacturers.

Compounding Pharmacy + 503B Outsourcing Facility Working Stocks. 503A + 503B compounding operations + 503B outsourcing facilities (PharMEDium, Cantrell Drug, B. Braun Medical Compounding) stock USP sodium chloride in 25-50-lb bags + 1000-lb supersacks at the ingredient warehouse for use in patient-specific + batched-sterile-compounded preparations under USP <795> non-sterile + USP <797> sterile + USP <800> hazardous-drug compounding standards. The 503B outsourcing facility market grew substantially after the 2012 New England Compounding Center fungal-meningitis tragedy + 2013 Drug Quality and Security Act (DQSA) creation of the 503B regulatory category.

3. Regulatory Hazard Communication

OSHA HazCom GHS Classification. USP pharmaceutical sodium chloride is not classified as a GHS hazardous substance. Non-flammable, non-combustible at any handling temperature. No GHS health-hazard classifications at oral, dermal, or inhalation routes (sodium chloride is GRAS per FDA 21 CFR 184.1721 + a fundamental food + dietary mineral). Inhalation of NaCl dust at industrial bulk-handling operations triggers nuisance-dust + respiratory-irritation classification at PEL above 15 mg/m³ total dust (OSHA general-industry threshold). Environmental: not bio-degradable but environmentally non-toxic at typical exposure scenarios; aquatic toxicity at high concentrations (fish LC₅₀ ~7000 mg/L). H-statements: typically none required. P-statements: P261 Avoid breathing dust at solid-handling; P403+P233 Store in well-ventilated container kept tightly closed (hygroscopic / deliquescent above 75% RH).

FDA cGMP Compliance Framework. Pharmaceutical USP sodium chloride used in finished drug products is regulated under 21 CFR Part 210 + 211 (finished pharmaceuticals) and 21 CFR Parts 600-680 (biologics). Identity testing per 21 CFR 211.84(d)(2) requires at least one specific identity test on each container received; USP identification by sodium-flame test + chloride-precipitation test + assay are the standard pharmacopeial identity panel. ICH Q3D + Q3C apply to elemental + residual-solvent impurities. Parenteral-grade NaCl carries additional bacterial endotoxin testing per USP <85> (typically under 0.5 EU/mg as raw-material specification) at incoming-material QC; sterile-fill formulation includes additional endotoxin + sterility validation per finished-product compendia.

USP-NF 43 Compendial Specifications. Pharmacopeial harmonized sodium chloride specifications: assay 99.0% minimum NaCl on dried basis; identification by sodium ion + chloride ion tests + IR spectrum; loss on drying under 0.5% at 105°C for 2 hours; insoluble matter under 0.005% w/w; alkalinity / acidity neutral on litmus / pH 4.5-7.0 in 5% w/v aqueous; bromide under 0.01%; iodide trace negative; nitrite negative; calcium + magnesium combined under 0.005% as Ca; iron under 2 ppm; aluminum under 0.5 ppm (parenteral-grade); arsenic under 1 ppm; barium negative; heavy metals under 5 ppm; phosphate under 0.0025%; sulfate under 0.02%; bacterial endotoxins per USP <85> under 0.5 EU/mg (parenteral-grade subgrade); microbial limits per USP <61> + <62> appropriate for intended administration route.

DOT and Shipping. USP sodium chloride is not regulated under 49 CFR DOT Hazardous Materials Regulations. No UN number, no hazard class, no packing group. Shipped as standard non-hazardous solid in 50-lb bags (consumer + small-pharma), 1000-2200-lb HDPE supersacks + bulk-bags, bulk-pneumatic-truck dry-bulk (10-24-ton truckload) for large-volume parenteral manufacturers, and (less commonly) saturated-brine bulk-tanker (heated tanker for some industrial customers).

EPA Air Regulations. Sodium chloride storage silos + bulk-handling not subject to NESHAP or NSPS air regulations beyond facility-wide nuisance-dust controls per OSHA + facility-engineering standards.

FDA GRAS Status. Sodium chloride holds GRAS status per FDA 21 CFR 184.1721 (direct human food additive affirmed GRAS) for use as flavoring agent + texturizer + dough-strengthener + preservative + processing aid. EU food-additive authorization E-number not assigned (NaCl is treated as fundamental food + dietary mineral rather than additive). USP-grade pharmaceutical sodium chloride exceeds food-grade purity in trace-impurity controls.

4. Storage System Specification

Bulk-Receipt and Raw-Material-Warehouse Storage. Pharmaceutical USP sodium chloride arrives at the manufacturing facility raw-material warehouse via 50-lb bags + 1000-2200-lb HDPE supersacks + bulk-pneumatic-truck dry-bulk (10-24-ton truckload) for large-volume parenteral manufacturers. Bulk-pneumatic-truck deliveries at large parenteral manufacturers (Baxter Mountain Home AR + Hospira Rocky Mount NC) transfer to dedicated dry-storage silos: HDPE rotomolded vertical bulk-bag-discharge silos (1000-50000 cubic-foot capacity), carbon-steel + epoxy-coated dry-bulk silos with bag-house dust-collection ventilation, or dedicated pharmaceutical-grade FDA-compliant resin-coated mild-steel silos. Solid NaCl bulk-handling triggers humidity-control at storage (NaCl is hygroscopic above 75% RH and deliquescent above 78% RH; tropical / humid-climate facilities require dehumidification + sealed-silo design to prevent moisture-uptake + caking).

Brine Tank Sizing. Brine-make-up + brine-storage tanks at parenteral manufacturing operations: 5000-50000-gallon HDPE rotomolded tanks for saturated-brine staging (saturated brine at 26.4% w/w NaCl), with brine-make-up via solid-NaCl charge + WFI dilution. The brine-make + dilute-to-formulation-strength sequence is the dominant pharmaceutical pattern; HDPE is preferred over stainless at brine-make service due to chloride-immunity + lower pitting risk. Dilute saline (under 5% NaCl) at the pre-formulation kettle uses 316L electropolished sanitary stainless tanks per ASME BPE-2022.

Compounding Pharmacy + 503B Outsourcing-Facility Working-Stock Storage. 503A + 503B compounding operations stock USP sodium chloride in 5-30 lb HDPE pails + 50-lb bags at the ingredient warehouse + non-sterile + sterile compounding cleanroom. Brine-make at 503B outsourcing facilities for batched-sterile-compounded saline preparations follows the same general pattern as large-parenteral-manufacturer brine-make scaled down to facility output. Working-stock turnover of 6-12 months for sealed bag + pail.

Product-Contact Formulation Tanks. Active formulation + compounding for finished IV-saline / hypertonic-saline / ophthalmic / dialysate-concentrate / nasal-saline preparations occurs in 316L electropolished sanitary stainless tanks per ASME BPE-2022 with internal surface finish Ra under 0.5 microns, all-welded 316L sanitary tri-clamp transfer piping, BPE diaphragm or ball valves, jacketed temperature control, top-mounted impeller agitation, CIP/SIP capability via hot-water + sanitizer cycles + steam-in-place sanitization. 316L is acceptable at dilute saline (under 5% NaCl) but NOT preferred at saturated brine + hot brine + stagnant + crevice geometries; super-austenitic (AL-6XN, 254 SMO) or duplex stainless (2205) is the upgrade material at aggressive brine service.

Secondary Containment. Brine-make + brine-storage tanks at pharmaceutical operations are placed inside HDPE secondary-containment pans sized to 110% of largest single tank capacity per facility-wide containment best-practice. Solid-NaCl silos may have spill-control catchments + dust-recovery hopper integration per facility-engineering standards.

Dust Control at Solid-Handling. Solid NaCl handling at supersack-discharge + bulk-bag-charging + silo-inlet stations creates moderate dust-loading potential; bag-house dust-collection ventilation + N95 dust-mask + proper engineering controls per OSHA 29 CFR 1910 + 29 CFR 1910.1000 PEL compliance. NaCl is a nuisance dust; not a hazardous-dust + not a combustible-dust at any particle-size range.

5. Field Handling Reality

Operator PPE. Pharmaceutical operators handling USP sodium chloride require standard pharmaceutical manufacturing PPE: cleanroom-grade gowning at sterile + cleanroom operations (large-volume parenteral fill-finish requires Class 5 / ISO 5 + Class 7 / ISO 7 cleanroom gowning per the EU GMP Annex 1 + FDA cGMP guidance), safety glasses + lab coat + closed-toe shoes at non-cleanroom ingredient warehouse + bulk-receipt operations, nitrile gloves at all liquid-handling operations to prevent product cross-contamination; N95 dust mask at solid-handling + supersack-discharge stations. Spill-response gear at the bulk-receipt area.

Microbial Bioburden Control. Solid + saturated-brine sodium chloride is essentially microbiostatic at high osmolarity (saturated NaCl water-activity ~0.75 places it well below most bacterial-growth thresholds). Diluted saline at 0.9% (isotonic) or 3-7% (hypertonic) supports microbial growth and requires sterile-filtration + closed-system handling at production. Bulk-receipt + warehouse storage of solid NaCl + saturated brine has minimal microbial concerns; dilution into formulation triggers strict sterile + endotoxin-controlled handling per parenteral-product cGMP.

Spill Response. Sodium chloride spill response is a low-hazard standard cleanup: (1) deploy mechanical brushes + shovel + dustpan for solid spill; absorbent pads for any aqueous brine spill, (2) collect into double-bagged poly waste for non-RCRA + non-hazardous-waste profiling and disposal under facility-specific waste streams (typically incineration or landfill for pharmaceutical-feedstock-residual NaCl), (3) wash spill area with water + mild detergent (NaCl's high water-solubility makes water + detergent the appropriate decontamination route), (4) document spill volume + decontamination + containment integrity for the facility deviation + investigation system per 21 CFR 211.192.

Slip Hazard. Brine spill creates slip hazard at any bulk-receipt + transfer + dispensing operation; solid-NaCl spill creates moderate slip + traction-loss hazard at floor level. Slip-resistant floor mats + secondary containment + immediate spill cleanup are essential at the bulk-receipt staging area + brine-make operations.

Hygroscopicity + Caking Awareness. Solid USP sodium chloride is hygroscopic above 75% RH and deliquescent above 78% RH; ambient + tropical / humid-climate storage creates moisture-uptake + caking + flow-property degradation concerns. Sealed-package storage + dehumidified silo + facility ambient-RH control (under 65% RH ideal) is the standard pattern at humid-climate pharmaceutical operations. Anti-caking additives are not used in USP-grade sodium chloride (some technical-grade industrial sodium chloride includes sodium-ferrocyanide or magnesium-carbonate anti-caking agents at trace levels not compatible with USP-grade purity specifications).

Decontamination of Cross-Contamination Spills. Pharmaceutical manufacturing under 21 CFR 211.42 + 21 CFR 211.46 + 21 CFR 211.67 cleaning + cross-contamination prevention requires documented cleaning of any spill area + adjacent equipment + drains + transfer-piping returning to compendial-clean status. NaCl spill at multi-product compounding bench triggers cross-contamination investigation, equipment-cleaning verification, and quality-deviation closure before resumption of compounding.

Talk to OneSource Plastics

Listed price covers tank + standard fitting package; LTL freight is quoted separately to your delivery ZIP. Call 866-418-1777, use our freight estimator, or try our chemical tank recommender to narrow material selection.